191 related articles for article (PubMed ID: 26646469)
1. Use of vaginal estrogen in Danish women: a nationwide cross-sectional study.
Meaidi A; Goukasian I; Lidegaard O
Acta Obstet Gynecol Scand; 2016 Mar; 95(3):280-4. PubMed ID: 26646469
[TBL] [Abstract][Full Text] [Related]
2. Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy.
Palacios S; Castelo-Branco C; Cancelo MJ; Vázquez F
Maturitas; 2005 Feb; 50(2):98-104. PubMed ID: 15653006
[TBL] [Abstract][Full Text] [Related]
3. [Local estrogen therapy--clinical implications--2012 update].
Kokot-Kierepa M; Bartuzi A; Kulik-Rechberger B; Rechberger T
Ginekol Pol; 2012 Oct; 83(10):772-7. PubMed ID: 23383564
[TBL] [Abstract][Full Text] [Related]
4. The use of two estrogen preparations (a combined contraceptive pill versus conjugated estrogen cream) intravaginally to treat urogenital symptoms in postmenopausal Thai women: a comparative study.
Chompootaweep S; Nunthapisud P; Trivijitsilp P; Sentrakul P; Dusitsin N
Clin Pharmacol Ther; 1998 Aug; 64(2):204-10. PubMed ID: 9728901
[TBL] [Abstract][Full Text] [Related]
5. Estrogens and the urogenital tract. Studies on steroid hormone receptors and a clinical study on a new estradiol-releasing vaginal ring.
Smith P
Acta Obstet Gynecol Scand Suppl; 1993; 157():1-26. PubMed ID: 8393609
[TBL] [Abstract][Full Text] [Related]
6. Effect of oral estriol on urogenital symptoms, vaginal cytology, and plasma hormone level in postmenopausal women.
Manonai J; Theppisai U
J Med Assoc Thai; 2001 Apr; 84(4):539-44. PubMed ID: 11460966
[TBL] [Abstract][Full Text] [Related]
7. A comparative multicenter study of the effects of continuous low-dose estradiol released from a new vaginal ring versus estriol vaginal pessaries in postmenopausal women with symptoms and signs of urogenital atrophy.
Henriksson L; Stjernquist M; Boquist L; Alander U; Selinus I
Am J Obstet Gynecol; 1994 Sep; 171(3):624-32. PubMed ID: 8092207
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women.
Dessole S; Rubattu G; Ambrosini G; Gallo O; Capobianco G; Cherchi PL; Marci R; Cosmi E
Menopause; 2004; 11(1):49-56. PubMed ID: 14716182
[TBL] [Abstract][Full Text] [Related]
9. Effect and safety of 17 beta-estradiol vaginal tablet in postmenopausal women with urogenital symptoms.
Manonai J; Theppisai U; Chittacharoen A
J Med Assoc Thai; 2001 Jul; 84(7):1015-20. PubMed ID: 11759960
[TBL] [Abstract][Full Text] [Related]
10. Effects of intravaginal estriol and pelvic floor rehabilitation on urogenital aging in postmenopausal women.
Capobianco G; Donolo E; Borghero G; Dessole F; Cherchi PL; Dessole S
Arch Gynecol Obstet; 2012 Feb; 285(2):397-403. PubMed ID: 21706345
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of vaginal use of topical estriol in postmenopausal women with urogenital atrophy.
Chuery AC; Speck NM; de Moura KF; Belfort PN; Sakano C; Ribalta JC
Clin Exp Obstet Gynecol; 2011; 38(2):143-5. PubMed ID: 21793275
[TBL] [Abstract][Full Text] [Related]
12. Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy.
Barentsen R; van de Weijer PH; Schram JH
Eur J Obstet Gynecol Reprod Biol; 1997 Jan; 71(1):73-80. PubMed ID: 9031963
[TBL] [Abstract][Full Text] [Related]
13. Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet.
Weisberg E; Ayton R; Darling G; Farrell E; Murkies A; O'Neill S; Kirkegard Y; Fraser IS
Climacteric; 2005 Mar; 8(1):83-92. PubMed ID: 15804736
[TBL] [Abstract][Full Text] [Related]
14. [Topical hormonal treatment and urogenital atrophy].
Sitruk-Ware R; Thomas JL
Praxis (Bern 1994); 1997 Aug; 86(33):1245-8. PubMed ID: 9381009
[TBL] [Abstract][Full Text] [Related]
15. Management of vulvovaginal atrophy-related sexual dysfunction in postmenopausal women: an up-to-date review.
Tan O; Bradshaw K; Carr BR
Menopause; 2012 Jan; 19(1):109-17. PubMed ID: 22011753
[TBL] [Abstract][Full Text] [Related]
16. One-year treatment persistence with local estrogen therapy in postmenopausal women diagnosed as having vaginal atrophy.
Portman D; Shulman L; Yeaw J; Zeng S; Uzoigwe C; Maamari R; Iyer NN
Menopause; 2015 Nov; 22(11):1197-203. PubMed ID: 25944522
[TBL] [Abstract][Full Text] [Related]
17. Vaginal estrogen therapy for the treatment of atrophic vaginitis.
Lynch C
J Womens Health (Larchmt); 2009 Oct; 18(10):1595-606. PubMed ID: 19788364
[TBL] [Abstract][Full Text] [Related]
18. From systemic hormone therapy to vaginal estrogen - a nationwide register study in Finland, 2003-2012.
Holm E; Aaltonen K; Heikkinen AM; Tiihonen M
Maturitas; 2014 Aug; 78(4):293-7. PubMed ID: 24934885
[TBL] [Abstract][Full Text] [Related]
19. Estradiol-releasing vaginal ring delivery system for urogenital atrophy. Experience over the past decade.
Bachmann G
J Reprod Med; 1998 Nov; 43(11):991-8. PubMed ID: 9839269
[TBL] [Abstract][Full Text] [Related]
20. Vaginal estradiol use and the risk for cardiovascular mortality.
Mikkola TS; Tuomikoski P; Lyytinen H; Korhonen P; Hoti F; Vattulainen P; Gissler M; Ylikorkala O
Hum Reprod; 2016 Apr; 31(4):804-9. PubMed ID: 26874358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
